Galapagos | GLPG - Operating Profit

Stock Price
29.40
Daily Change
0.24 0.82%
Monthly
7.69%
Yearly
34.49%
Q1 Forecast
27.75

Galapagos reported EUR-41.67M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
argenx SE USD 349.97M 146.13M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Genmab DKK 360M 172M Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Incyte USD 431.31M 120.49M Sep/2025
Merck EUR 1.21B 180M Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025